This announcement is a separate document:
湖北瑞通天元律师事务所关于嘉必优生物技术（武汉）股份有限公司调整2022年限制性股票激励计划相关事项的法律意见书
Legal opinion of Hubei Ruitong Tianyuan Law Firm on matters relating to the adjustment of the 2022 restricted stock incentive plan by Jiabiyou Biotechnology (Wuhan) Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.